Scriptaid Treatment Decreases DNA Methyltransferase 1 Expression by Induction of MicroRNA-152 Expression in Porcine Somatic Cell Nuclear Transfer Embryos.
Abnormal epigenetic reprogramming of donor nuclei after somatic cell nuclear transfer (SCNT) is thought to be the main cause of low cloning efficiencies. A growing body of evidence has demonstrated a positive role of Scriptaid, a histone deacetylase inhibitor (HDACi) that belongs to an existing class of hydroxamic acid-containing HDACis, on the development competence of cloned embryos in many species. The present study investigated the effects of Scriptaid on the development of porcine SCNT embryos in vitro and its mechanism. Treatment with 300 or 500 nM Scriptaid for 20 h after activation significantly increased the percentage of SCNT embryos that developed to the blastocyst stage and the total number of cells per blastocyst and significantly decreased the percentage of apoptotic cells in blastocysts. Scriptaid treatment significantly increased the level of histone H3 acetylated at K9 and the conversion of 5-methylcytosine into 5-hydroxymethylcytosine and significantly decreased the level of histone H3 trimethylated at K9 at the pronuclear stage. As a potential mechanism for the DNA methylation changes, our results showed that the expression of DNA methyltransferase 1 was frequently down-regulated in Scriptaid-treated embryos in comparison with untreated embryos and was inversely correlated to endogenous microRNA-152 (miR-152). Taken together, these findings illustrated a crucial functional crosstalk between miR-152 and DNMT1. Meanwhile, mRNA and protein levels of POU5F1 and CDX2 were increased in Scriptaid-treated embryos. mRNA levels of Caspase3, and Bax were significantly decreased and that of Bcl-xL was significantly increased in Scriptaid-treated embryos. In conclusion, these observations would contribute to uncover the nuclear reprogramming mechanisms underlying the effects of Scriptaid on the improvement of porcine SCNT embryos.
Department of Animal Science, Chungbuk National University, Cheongju, Chungbuk, 361-763, Republic of Korea; Brain Korea 21 center for Bio-Resource Development, Cheongju, Chungbuk, 361-763, Republic of Korea.
Shuang
S
Liang
Department of Animal Science, Chungbuk National University, Cheongju, Chungbuk, 361-763, Republic of Korea; Brain Korea 21 center for Bio-Resource Development, Cheongju, Chungbuk, 361-763, Republic of Korea.
Ming-Hui
MH
Zhao
Department of Animal Science, Chungbuk National University, Cheongju, Chungbuk, 361-763, Republic of Korea; Brain Korea 21 center for Bio-Resource Development, Cheongju, Chungbuk, 361-763, Republic of Korea.
Jeong-woo
JW
Choi
Department of Animal Science, Chungbuk National University, Cheongju, Chungbuk, 361-763, Republic of Korea; Brain Korea 21 center for Bio-Resource Development, Cheongju, Chungbuk, 361-763, Republic of Korea.
Nam-Hyung
NH
Kim
Department of Animal Science, Chungbuk National University, Cheongju, Chungbuk, 361-763, Republic of Korea; Brain Korea 21 center for Bio-Resource Development, Cheongju, Chungbuk, 361-763, Republic of Korea.
Xiang-Shun
XS
Cui
D000818:Animals; D017209:Apoptosis / Q000235:genetics; D001755:Blastocyst / Q000187:drug effects / Q000378:metabolism; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics*; D004622:Embryo, Mammalian / Q000196:embryology / Q000378:metabolism; D047108:Embryonic Development / Q000187:drug effects / Q000235:genetics; D005786:Gene Expression Regulation / Q000187:drug effects*; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology*; D006898:Hydroxylamines / Q000494:pharmacology*; D035683:MicroRNAs / Q000235:genetics*; D053652:Nuclear Transfer Techniques; D011804:Quinolines / Q000494:pharmacology*; D013552:Swine; D013997:Time Factors
D056572:Histone Deacetylase Inhibitors; D006898:Hydroxylamines; D035683:MicroRNAs; D011804:Quinolines; C410733:scriptaid; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases